Nutrition and mortality in hemodialysis

Journal of the American Society of Nephrology

Volumn 6, Issue 5, 1995, Pages 1329-1341

  Bergström, Jonas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Albumin; Anorexia; Cachexia; Catabolism; Malnutrition

Indexed keywords

ALBUMIN BLOOD LEVEL; ANOREXIA; CACHEXIA; CATABOLISM; CHRONIC KIDNEY FAILURE; HEMODIALYSIS; HUMAN; MALNUTRITION; MORTALITY; PRIORITY JOURNAL; REVIEW;

HUMANS; KIDNEY FAILURE, CHRONIC; NUTRITION DISORDERS; NUTRITIONAL STATUS; RENAL DIALYSIS; SURVIVAL RATE;

EID: 0028862235     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (146)

1. Scribner BH, Buri R, Caner JEZ, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent hemodialysis: A preliminary report. ASAIO J 1960;4:114-122.
2. Young VR: Nutritional requirements of normal adults. In: Mitch WE, Klahr S. Eds. Nutrition and the Kidney. Boston: Little, Brown and Company: 1993:1-34.
3. Chandra RK: Nutrition, immunity, and infection: present knowledge and future direction. Lancet 1983; 1:688-691.
4. Windsor JA, Knight GS, Hill GL: Wound healing response in surgical patients: recent food intake is most important than nutritional status. Br J Surg 1988;75: 135-137.
5. Lindholm B, Bergström J: Nutritional management of patients undergoing peritoneal dialysis. In: Nolph KD, Ed. Peritoneal Dialysis. Boston: Kluwer Academic Publishers; 1989:230-260.
6. Steinman TI, Mitch WE: Nutrition in dialysis patients. In: Maher MF. Ed. Replacement of Renal Function by Dialysis. Boston: Kluwer Academic Publishers; 1989: 1088-1106.
7. Mazess RB, Barden HS, Bisek JP, Hanson J: Dualenergy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990;51:1106-1112.
8. Segal KR, Burastero S, Chun A, Coronel P, Pierson RN Jr, Wang J: Estimation of extracellular and total body water by multiple-frequency bioelectrical-impedance measurement. Am J Clin Nutr 1991;54:26-29.
9. Formica C, Atkinson MG, Nyulasi I, McKay J, Heale W, Seeman E: Body composition following hemodialysis: Studies using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Osteoporosis Int 1993;3:192-197.
10. Cosentino F, Pexa D, Dennis VW, Donatucci D, Ellis P, Piedmonte M: Body composition and nutritional analysis using dual energy X-ray absorptiometry scans (DEXA) and a standard composite nutritional index (CN) in patients on hemodialysis. J Am Soc Nephrol 1994;5:490.
11. Katzarski KS, Anderstam B, Nordenström J, Nilsson M, Bergström J: Dual-energy x-ray absorptiometry (DEXA) and multifrequency bioimpedance (MFB) for assessment of nutritional status in chronic hemodialysis (HD) patients. Blood Purif 1994;12:156.
12. Bergström J, Alvestrand A, Fürst P, Hultman E, Widstam-Attorps U: Muscle intracellular electrolytes in patients with chronic uremia. Kidney Int 1983;[Suppl 16]:S153-S160.
13. Crim MC, Calloway DH, Margen S: Creatinine metabolism in men: Creatine pool size and turnover in relation to creatine intake. J Nutr 1976;106:371-381.
14. Levey S, Perrone R, Madias N: Serum creatinine and renal function. Annu Rev Med 1988;39:465-490.
15. Forsberg AM, Nilsson E, Wernerman J, Bergström J, Hultman E: Muscle composition in relation to age and sex. Clin Sci 1991;81:249-256.
16. Lo WK, Prowant BF, Moore HL, et al.: Comparison of different measurements of lean body mass in normal individuals and in chronic peritoneal dialysis patients. Am J Kidney Dis 1994;23:74-85.
17. Detsky AS, McLaughlin JR, Baker JP, et al.: What is subjective global assessment? JPEN 1987;11:8-13.
18. Young GA, Kopple JD, Lindholm B, et al.: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 1991;17:462-471.
19. Enia G, Sicuso C, Alati G, Zoccali C: Subjective global assessment of nutrition in dialysis patients. J Am Soc Nephrol 1991:323.
20. Sengar DPS, Rashid A, Harris JF: In vitro cellular immunity and in vivo delayed hypersensitivity in uremic patients maintained on hemodialysis. Archs Allergy Appl Immun 1974;47:829.
21. Schaeffer G, Heinze V, Jontofsohn R, et al.: Amino acid and protein intake in RDT patients. A nutritional and biochemical analysis. Clin Nephrol 1975;3:228-233.
22. Delaporte C, Bergström J, Broyer M: Variations in muscle cell protein of severely uremic children. Kidney Int 1976;10:239-245.
23. Bansal VK, Popli S, Pickering J, Ing TS, Vertuno LL, Hano JE: Protein-calorie malnutrition and cutaneous anergy in hemodialysis maintained patients. Am J Clin Nutr 1980;33:1608-1611.
24. Young GA, Swanepoel CR, Croft MR, Hobson SM, Parsons FM: Anthropometry and plasma valine, amino acids, and proteins in the nutritional assessment of hemodialysis patients. Kidney Int 1982;21:492-499.
25. Schoenfeld PY, Henry RR, Laird NM, Roxe DM: Assessment of nutritional status of the National Cooperative Study population. Kidney Int 1983;23[Suppl 13]:80-88.
26. Bergström J, Alvestrand A, Fürst P: Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 1990; 38:108-114.
27. Guarnieri G, Toigo G, Situlin R, et al.: Muscle biopsy studies in chronically uremic patients: evidence for malnutrition. Kidney Int 1983;24[Suppl 16]:187-193.
28. Wolfson M, Strong CJ, Minturn D, Gray DK, Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 1984;37:547-555.
29. Marckmann P: Nutritional status and mortality of patients in regular dialysis therapy. J Intern Med 1989; 226:429-432.
30. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
31. Allman MA, Allen BJ, Stewart PM, et al.: Body protein of patients undergoing hemodialysis. Eur J Clin Nutr 1990;44:123-131.
32. Jacob V, Le Carpentier JE, Salzano S, et al.: IGF-I, a marker of undernutrition in hemodialysis patients. Am J Clin Nutr 1990;52:39-44.
33. Rayner HC, Sroud DB, Salamon KM, et al.: Anthropometry underestimates body protein depletion in hemodialysis patients. Nephron 1991;59:33-40.
34. Oksa H, Ahonen K, Pasternack A, Marnela KM: Malnutrition in hemodialysis patients. Scand J Urol Nephrol 1991;25:157-161.
35. Bilbrey GL, Cohen TL: Identification and treatment of protein calorie malnutrition in chronic hemodialysis patients. Dial Transplant 1989;18:669-677.
36. Bárány P, Pettersson E, Ahlberg M, Hultman E, Bergström J: Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin. Clin Nephrol 1991;35:270-279.
37. Talemaitoga AS, Sanders BA, Hinton D, Lynn KL: Nutritional status of home hemodialysis patients. Aust NZ J Med 1989;19:303-309.
38. Bergström J, Lindholm B: Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int 1993;43[Suppl 40]:S39-S50.
39. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship THJ: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 1993;265:E230-235.
40. Lim VS, Bier DM, Flanigan MJ, Sum-Ping ST: Acidosis increased amino acid oxidation in chronic renal failure (CRF) patients. J Am Soc Nephrol 1993;4:252.
41. Hara Y, May RC, Kelly RC, Mitch WE: Acidosis, not azotemia, stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 1987;32:808-814.
42. Garibotto G, Russo R, Sofia A, et al.: Skeletal muscle protein synthesis and degradation in patients with chronic renal failure.
43. May RC, Hara Y, Kelly RA, Block KP, Buse M, Mitch WE: Branched-chain amino acid metabolism in rat muscle: Abnormal regulation in acidosis. Am J Physiol 1987;252:E712-E718.
44. Mitch WE, Medina R, Grieber S, et al.: Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 1994; 93:2127-2133.
45. Bergström J, Alvestrand A, Fürst P: Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 1990; 38:108-114.
46. Lowrie EG, Lew NL: Commonly measured laboratory variables in hemodialysis patients: Relationships among them and to death risk. Semin Nephrol 1992; 12:276-283.
47. Bergström J: Metabolic acidosis and nutrition in dialysis patients. Blood Purif 1994, in press.
48. Lowrie EG: Chronic dialysis treatment: Clinical out-come and related processes of care. Am J Kidney Dis 1994;24:255-266.
49. Papadoyannakis NJ, Stefanidis CJ, McGeown M: The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nur 1984;40:623-627.
50. Löfberg E, Wernerman J, Bergström J: Branchedchain amino acids in muscle increase during correction of metabolic acidosis in hemodialysis (HD) patients. J Am Soc Nephrol 1993;4:363.
51. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfson M, Humphreys MH: Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978;14:491-500.
52. Lim VS, Flanigan MJ: The effect of interdialytic interval on protein metabolism: Evidence suggesting dialysis-induced catabolism. Am J Kidney Dis 1989;14:96-100.
53. Löfberg E, Wernerman J, Norée LO, Decken A, Vinnars E: Ribosome and free amino acid content in muscle during hemodialysis. Kidney Int 1991;39:984-989.
54. Lim VS, Bier DM, Flanigan MJ, Sum-Ping ST: The effect of hemodialysis on protein metabolism. A leucine kinetic study. J Clin Invest 1993;91:2429-2436.
55. Wolfson M, Jones MR, Kopple JD: Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982;21:500-506.
56. Gutierrez A, Bergström J, Alvestrand A: Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int 1994;46:814-822.
57. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-837.
58. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995;47:573-578.
59. Cheung AK: Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990;1:150-161.
60. Gutierrez A, Alvestrand A, Wahren J, Bergström J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990;38:487-494.
61. Gutierrez A, Bergström J, Alvestrand A: Protein catabolism in sham-hemodialysis: the effect of different membranes. Clin Nephrol 1992;38:20-29.
62. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW: Infusion of tumor necrosis factor. Cachectin promotes muscle catabolism in the rat. J Clin Invest 1989;83:1614-1622.
63. Hakim RM, Wingard RL, Ikizler TA, et al.: Effects of biocompatibility on nutritional status in chronic hemodialysis patients (CHD). J Am Soc Nephrol 1994;5:451.
64. Monteon FJ, et al.: Energy expenditure in patients with chronic renal failure. Kidney Int 1986;30:741.
65. Kopple JD, Chumlea WC, Gassman JJ, et al.: Relationship between GFR and nutritional status. Results from the MDRD study. J Am Soc Nephrol 1994;5:325.
66. Kishi K, Miytani K, Inoue G: Requirement and utilization of egg protein by Japanese young men with marfinal intakes of energy. J Nutr 1978;198:658-669.
67. Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA, Kopple JD: Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 1989;35:704-711.
68. Arnold WC, Danford D, Holliday MA: Effects of caloric supplementation on growth in children with uremia. Kidney Int 1983;24:205-209.
69. Lowrie EG, Laird NM, Henry RR: Protocol for the National Cooperative Dialysis Study. Kidney Int 1983; 23[Suppl 13]:S11-S18.
70. Bergström J, Mamoun AH, Anderstam B, Södersten P: Middle molecules (MM) isolated from uremic ultrafiltrate (UF) and normal urine induce dose-dependent inhibition of appetite in the rat. J Am Soc Nephrol 1994;5:488.
71. Lindsay RM, Spanner E: A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 1989;13:382-389.
72. Lysaght MJ, Pollock CA, Hallet MD, Ibels LS, Farrell PC: The relevance of urea kinetic modeling to CAPD. Trans Am Soc Artif Intern Organs 1989;35:784-790.
73. Lindsay RM, Spanner E, Heidenheim P, Kortas C, Blake PG: PCR, Kt/V and membrane. Kidney Int 1993; 43[Suppl 41]:S268-S273.
74. Movilli E, Mombelloni S, Gaggiotti M, Maiorca R: Effect of age on protein catabolic rate, morbidity, and mortality in uraemic patients with adequate dialysis. Nephrol Dial Transplant 1993;8:735-739.
75. Morgenstern A, Winkler J, Narkis R, et al.: Adequacy of dialysis and nutritional status in hemodialysis patients. Nephron 1994;66:438-441.
76. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985; 28:526-534.
77. Harty JC, Boulton H, Curwell J, et al.: The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 1994;45:103-109.
78. Raja RM, Ijelu G, Gofdstein M: Influence of Kt/V and protein catabolic rate on hemodialysis morbidity. A long-term study. ASAIO J 1992;38:M179-180.
79. Burrowes JD, Lyons TA, Kaufman AM, Levin NW: Improvement in serum albumin with adequate hemodialysis. J Renal Nutr 1993;3:171-176.
80. Hakim RA, Breyer J, Ismali N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994;23:661-669.
81. United States Renal Data System. 1994 Annual Data Report. Washington, DC: U.S. Department of Health and Human Services, Health Care Financing Administration, Bureau of Data Management and Strategy; 1994.
82. European Dialysis and Transplant Association-European Renal Association. EDTA/ERA Registry Report, Demography of Dialysis and Transplantation in Europe, 1984. Nephrol Dial Transplant 1986;1:1-8.
83. Piccoli GB, Salomone M, Bonello F, et al.: Dialysis choice in the elderly: Cause or effect of relevant clinical problems? Nephrol Dial Transplant 1993;8:1006.
84. Harter HR: Review of significant findings from the National Cooperative Dialysis Study and recommendations. Kidney Int 1983;23[Suppl 13]:107-112.
85. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985; 28:526-534.
86. Parker TF, Reed RB, Lowrie EG: Description of the participating centers and the patient population in the National Cooperative Dialysis Study. Kidney Int 1983; [Suppl 13]:37-41.
87. Parker TF, Laird NM, Lowrie EG: Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int 1983;23[Suppl 13]:S42-S49.
88. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983;24[Suppl 16]:199-203.
89. Degoulet P, Legrain M, Reach I, et al.: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 1982;31:103-110.
90. Shapiro JI, Argy WP, Rakowski TA, Chester A, Siemsen AS, Schreiner GE: The unsuitability of BUN as a criterion for prescription dialysis. Trans Am Soc Artif Intern Organs 1983;29:129-134.
91. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006.
92. Goldwasser P, Michel MA, Collier J, et al.: Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 1993;22:215-225.
93. Goldwasser P, Mittman N, Antignani A, et al.: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993;3:1613-1622.
94. Churchill DN, Taylor DW, Cook RJ, et al.: Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19:214-234.
95. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115-119.
96. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23:272-282.
97. Jungers P, Zingraff J, Albouze G, et al.: Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant 1993;8:1089-1093.
98. Norée LO, Bergström J: Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. Clin Nephrol 1975;3:195-203.
99. Walser M: Does prolonged protein restriction preceding dialysis lead to protein malnutrition at the onset of dialysis? Kidney Int 1993;44:1139-1144.
100. Klein S: The myth of serum albumin as a measure of nutritional status. Gastroenterology 1990;99:1845-1846.
101. Lentner C, Ed. Geigy Scientific Tables. Vol. 3. Physical Chemistry, Composition of Blood, Hematology, Somatometric Data. 8th ed. Basel: Ciba-Geigy Ltd; 1984.
102. Kushner I: The phenomenon of the acute phase response. Ann NY Acad Sci 1982;389:3948.
103. Dinarello CA: Biology of interleukin 1. FASEB J 1988; 2:108-115.
104. Castell JV, Andus T, Kunz D, et al.: Interleukin-6, the major regulator of acute-phase protein synthesis in man and rat. Ann NY Acad Sci 1989;557:87-99.
105. Ballmer PE, Ballmer-Hofer K, Repond F, et al.: Acute suppression of albumin synthesis in systemic inflammatory disease: An individually graded response of rat hepatocytes. J Histochem Cytochem 1992;40:201-206.
106. Tullis JL: Albumin 2: Guidelines for clinical use. JAMA 1977;237:460-463.
107. Fleck A, Hawker F, Wallace PI, et al.: Increased vascular permeability. A major cause of hypoalbuminaemia in disease and injury. Lancet 1985;1:781-784.
108. Grossman J, Yalow AA, Weston RE: Albumin degradation and synthesis as influenced by hydrocortisone, corticotropin and infection. Metabolism 1960;9:528-550.
109. Parving HH, Rasmussen M: Transcapillary escape rate of albumin and plasma volume in short- and long-term juvenile diabetics. Scand J Clin Lab Invest 1973;32:81-87.
110. Parving HH, Gyntelberg F: Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973;32:643-651.
111. Parving HH, Ranek L, Lassen NA: Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver. Scand J Clin Lab Invest 1977;37:643-648.
112. Herrmann FR, Safran C, Levkoff SE, Minaker KL: Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992;152:125-130.
113. Kaysen GA, Rathorne V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-516.
114. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L: The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Peritoneal Dial Int 1994;14:121-126.
115. Ritz E, Vallance P, Nowicki M: The effect of malnutrition on cardiovascular mortality in dialysis patients: is L-arginine the answer? Nephrol Dial Transplant 1994; 9:129-130.
116. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339: 572-575.
117. Anderstam B, Katzarski K, Bergström J: Methylargin-ines in uremia. J Am Soc Nephrol 1994;5:572.
118. Alvestrand A, Fürst P, Bergström J: Intracellular amino acids in uremia. Kidney Int 1983;24[Suppl 16]: S9-S16.
119. Mattern WD, Hak LJ, Lamanna RW, Teasley KM, Laffell MS: Malnutrition, altered immune function, and the risk of infection in maintenance hemodialysis patients. Am J Kidney Dis 1982;1:206-218.
120. Keane WF, Maddy MF: Host defenses and infectious complications in maintenance hemodialysis patients. In: Maher JF, Ed. Replacement of Renal Function. 3rd Ed. Boston: Kluwer Academic Publ.: 1989:865-880.
121. Ganger DN, Gabel JC, Drake RE, Taylor AE: Physiologic basis for the clinical use of albumin solutions. Surg Gynecol Obstet 1978;146:97-104.
122. Emerson TE: Unique features of albumin: a brief review. Crit Care Med 1989;17:690-694.
123. Gulyassy PF, Depner TA: Impaired binding of drugs and endogenous ligands in renal diseases. Am J Kidney Dis 1983;2:578-601.
124. Blackburn GL, Driscoll DF: Time to abandon routine albumin supplementation. Crit Care Med 1992;20: 157-158.
125. Parker TF III, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994;23:670-680.
126. Bergström J: Nutritional requirements of hemodialysis patients. In: Mitch WE, Klahr S, Eds. Nutrition and the Kidney. 2nd Ed. Boston: Little, Brown and Company: 1993;263-289.
127. Cano N, Labastie-Coeyrehourq J, Lacombe P, et al.: Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr 1990;52:726-730.
128. Toigo G, et al.: Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients. Kidney Int 1989;27:5278.
129. Piraino AJ, Firpo JJ, Powers DV: Prolonged hyperalimentation in catabolic chronic dialysis therapy patients. JPEN 1981;5:463-477.
130. Allman MA, Yau DF, Tiller DJ, et al.: The effect of dietary glucose polymer supplementation on the nutrition and plasma amino acids of hemodialysis patients. J Renal Nutr 1992;2:59-66.
131. Vehe KL, Brown RO, Moore LW, Acchiardo SR, Luther RW: The efficacy of nutrition support in infected patients with chronic renal failure. Pharmacotherapy 1991;11:303-307.
132. Foulks CJ, Goldstein J, Kelly MP, Hunt JM: Indications for the use of intradialytic parenteral nutrition in the malnourished hemodialysis patients. J Renal Nutr 1991;1:23-33.
133. Siskind MS, Lien YHH: Effect of intradialytic parenteral nutrition on quality of life in hemodialysis patients. Int J Artif Organs 1993;16:599-603.
134. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 1994;23:808-816.
135. Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG: The effect of intradialytic parenteral nutrition on survival in hemodialysis patients. 1994;24:912-920.
136. Bilbrey GL: Is intradialytic parenteral nutrition of benefit in hemodialysis patients? IDPN is beneficial for selected dialysis patients. Semin Dial 1993;6:168-170.
137. Wolfson M: IDNP is of no proven benefit in hemodialysis patients. Semin Dial 1993;6:170-173.
138. Wilmore DW: Catabolic illness strategies for enhancing recovery. N Engl J Med 1990;323:56-64.
139. Fine RN, Pyke-Grimm K, Nelson PA, et al.: Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1 to 3 year) outcome. Pediatr Nephrol 1991;5:477-481.
140. Tonshoff B, Haffner D, Mehls O, et al.: Efficacy and safety of growth hormone treatment in short children with renal allografts: Three year experience. Kidney Int 1993;44:199-207.
141. Ziegler TR, Young LS, Manson JM, Wilmore DW: Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann Surg 1988;208:6-16.
142. Schulman G, Wingard RL, Hutchinson RL, Lawrence P, Hakim RM: The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 1993;21:527-534.
143. Kopple J: The rationale for the use of growth hormone or insulin-like growth factor-1 in adult patients with renal failure. Miner Electrolyte Metab 1992;18:269-275.
144. Peng SC, Fouque D, Kopple JD: Insulin-like growth factor-1 causes anabolism in malnourished CAPD patients. J Am Soc Nephrol 1993;4:414.
145. Fouque D, Peng SC, Kopple JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 1995;47:876-883.
146. Miller S, Mouton M, Ace M, Hammermann MR: Effects of IGF-1 on renal function in end-stage chronic renal failure. Kidney Int 1994;46:201-207.